bih.button.backtotop.text
BROWSE BY TEST NAME
%
1
2
3
5
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Clear
 
Test Code:
090-71-4004

Order Name:
Pharmacogenetics in DPYD **

 
Useful For:

Providing information relevant to medications metabolized by DPYD

ใช้เป็นข้อมูลทางเภสัชพันธุศาสตร์ของผู้ป่วย เพื่อประกอบการให้ปริมาณ (dose) ของยา  5-fluorouracil (5-FU) หรือ capecitabine chemotherapy treatment ที่เหมาะสมกับแต่ละบุคคล

 
Methodology:
Polymerase chain reaction
 
AliasesName:
PGx for DYPD
Drug-gene DYPD
 
 
 
Test Code:
090-71-4004

Order Name:
Pharmacogenetics in DPYD **

 
Patient Preparation:
N/A
 
Collection Specimen Or Container:
Blood/ K3 EDTA (Lavender Top) 3 mL, 2 tubes
 
Specimen Testing Type:
Whole Blood EDTA, minimum volume 3 mL
 
Sub Mission Container:
Original tube
 
Rejection Criteria:
Hemolysis: Hemolysis interfere
Other: Over Stability / Frozen specimen will be reject.
 
Specimen Stabillity:
Specimen Type Temperature Time
Whole blood, EDTA Ambient  Same day
Refrigerated, 2oC to 8oC 7 days
 
 
 
Test Code:
090-71-4004

Order Name:
Pharmacogenetics in DPYD **

 
Method detail:
Polymerase chain reaction
 
Schedule:
N/A **Sent Out to Ramathibodi
 
Turnaround Time:
Received specimen to report within 3-5 days
(exception for official holidays)
 
Performing Location:
Ramathibodi
Referral Lab Services, Laboratory Department 14160-2
 
 
 
Test Code:
090-71-4004

Order Name:
Pharmacogenetics in DPYD **

 
 
Clinical Information:
Pharmacogenetics in DPYD test is associated with 5-fluorouracil and capecitabine drug sensitivity. Variation in the DPYD gene is associated with dihydropyrimidine dehydrogenase (DPD) deficiency. Patient who have variations identified in the DPYD may benefit from genetic consultation.
 
Clinical Reference:
Ramathibodi Laboratory Guide book 2560-2562